Multiple Myeloma (MM) - Market Outlook 2030

Multiple Myeloma (MM) - Market Outlook 2030

This report provides an overview of the therapeutic area and market size for the 7 major markets.

Executive Summary
  • Addressable Patient Pool
  • Major Players in the Market
  • Market Dynamics
  • Market Forecast
Disease Understanding
  • Overview
  • Etiology
  • Symptoms
  • Diagnostic Algorithm
  • Treatment Algorithm
  • Current Standard of Care
7MM Epidemiology Overview
  • United States: Epidemiology Outlook
    • Disease Burden
    • Patient Demographics
    • Diagnosed Patient Pool
    • Treatable Patient Pool
    • Epidemiology Forecast
  • EU-5 Countries: Epidemiology Outlook
    • Germany Epidemiology Size
      • Disease Burden
      • Patient Demographics
      • Diagnosed Patient Pool
      • Treatable Patient Pool
      • Epidemiology Forecast
    • France Epidemiology Size
      • Disease Burden
      • Patient Demographics
      • Diagnosed Patient Pool
      • Treatable Patient Pool
      • Epidemiology Forecast
    • Italy Epidemiology Size
      • Disease Burden
      • Patient Demographics
      • Diagnosed Patient Pool
      • Treatable Patient Pool
      • Epidemiology Forecast
    • Spain Epidemiology Size
      • Disease Burden
      • Patient Demographics
      • Diagnosed Patient Pool
      • Treatable Patient Pool
      • Epidemiology Forecast
    • United Kingdom Market Outlook
      • Disease Burden
      • Patient Demographics
      • Diagnosed Patient Pool
      • Treatable Patient Pool
      • Epidemiology Forecast
  • Japan Market Outlook
    • Disease Burden
    • Patient Demographics
    • Diagnosed Patient Pool
    • Treatable Patient Pool
    • Epidemiology Forecast
Unmet Needs
Emerging Therapies
  • Competitive Landscape
  • Pipeline Benchmarking
  • Key Product Profiles
  • Ixazomib: Oncotherapeutics/ Takeda
    • Product Description
    • Regulatory Milestones
    • Clinical Development
    • Safety and efficacy
  • Magrolimab: Gilead Sciences
    • Product Description
    • Regulatory Milestones
    • Clinical Development
    • Safety and efficacy
7MM Market Analysis
  • Key Insights
  • Market Forecast Assumptions
  • Market Size of Multiple Myeloma (MM) in 7MM countries
  • Market Size of Multiple Myeloma (MM) by therapies in 7MM
  • United States: Market Outlook
    • Total Market size of Multiple Myeloma (MM) in the US
    • Market Size of Multiple Myeloma (MM) by Therapies in the US
  • EU-5 Countries: Market Outlook
    • Germany Market Size
      • Total Market Size of Multiple Myeloma (MM) in Germany
      • Market Size of Multiple Myeloma (MM) by Therapies in Germany
    • France Market Size
      • Total Market Size of Multiple Myeloma (MM) in France
      • Market Size of Multiple Myeloma (MM) by Therapies in France
    • Italy Market Size
      • Total Market Size of Multiple Myeloma (MM) in Italy
      • Market Size of Multiple Myeloma (MM) by Therapies in Italy
    • Spain Market Size
      • Total Market Size of Multiple Myeloma (MM) in Spain
      • Market Size of Multiple Myeloma (MM) by Therapies in Spain
    • United Kingdom Market Size
      • Total Market Size of Multiple Myeloma (MM) in the UK
      • Market Size of Multiple Myeloma (MM) by Therapies in the UK
  • Japan Market Outlook
    • Total Market Size of Multiple Myeloma (MM) in Japan
    • Market Size of Multiple Myeloma (MM) by Therapies in Japan
  • Market Drivers
  • Market Barriers